Literature DB >> 11260935

Paying for graduate medical education: the debate goes on.

J P Newhouse, G R Wilensky.   

Abstract

The debate over Medicare payments for graduate medical education has been conducted under the premise that such payments cover the added costs of training. Standard economic theory suggests that residents bear the costs of their training, implying that the additional costs of teaching hospitals are not attributable to training per se but to some combination of a different patient care product, unmeasured case-mix differences, and the costs of clinical research. As a result, payment for the additional patient care costs at teaching hospitals should come from the Medicare trust fund; any subsidies for training should come from general revenues.

Entities:  

Mesh:

Year:  2001        PMID: 11260935     DOI: 10.1377/hlthaff.20.2.136

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  5 in total

Review 1.  Medicare financing of graduate medical education.

Authors:  Eugene C Rich; Mark Liebow; Malathi Srinivasan; David Parish; James O Wolliscroft; Oliver Fein; Robert Blaser
Journal:  J Gen Intern Med       Date:  2002-04       Impact factor: 5.128

2.  Money for nothing? The net costs of medical training.

Authors:  Pedro P Barros; Sara R Machado
Journal:  Health Care Manag Sci       Date:  2010-09

Review 3.  Financing graduate medical education.

Authors:  Samuel Frank
Journal:  Nat Clin Pract Neurol       Date:  2008-11-04

4.  Assessing the Training Costs and Work of Diagnostic Radiology Residents Using Key Performance Indicators - An Observational Study.

Authors:  Marta E Heilbrun; Brad Poss; Luca Boi; Yoshimi Anzai; Nan Hu; Robert S Kaplan
Journal:  Acad Radiol       Date:  2019-08-31       Impact factor: 3.173

5.  Does experience matter? A comparison of the practice of attendings and residents.

Authors:  Mary E Charlson; Jwala Karnik; Mitchell Wong; Charles E McCulloch; James P Hollenberg
Journal:  J Gen Intern Med       Date:  2005-06       Impact factor: 5.128

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.